Definitive Healthcare Sets Date for Annual and Q4 2025 Financial Release

Definitive Healthcare US24477E1038

Investors in Definitive Healthcare (NASDAQ: DH) now have a date for the company’s upcoming financial disclosure. The healthcare data intelligence specialist will report its fourth quarter and full-year 2025 results after the U.S. market closes on February 26, 2026. This announcement will provide a critical look at the company's recent operational performance and future trajectory.

The market will be watching closely to see if the company can maintain its recent positive momentum. In the prior quarter, Definitive Healthcare posted earnings of $0.07 per share, which surpassed analyst consensus estimates of $0.06. The forthcoming report will indicate whether this trend of exceeding expectations is sustainable.

In a separate, routine filing ahead of the earnings release, the company disclosed an insider transaction. Chief Financial Officer Casey Heller disposed of 1,469 shares on February 1. According to the accompanying statement, this sale was executed solely to cover tax obligations related to the vesting of equity awards. Following this transaction, Heller retains a substantial direct ownership stake of 1,274,021 shares, signaling continued significant investment in the company's future.

Presentation and Conference Call Details

The complete financial statements and management's outlook for the new fiscal year will be made public on Thursday, February 26. Subsequently, the executive team will host a conference call for analysts and investors beginning at 11:00 p.m. Central European Time (5:00 p.m. Eastern Time). This call will offer management an opportunity to discuss the quarterly and annual figures in detail and to comment on the firm's strategic direction.

• Earnings Release Date: February 26, 2026 (after market close)
• Previous Quarterly EPS: $0.07 (consensus estimate was $0.06)
• CFO's Direct Holdings: 1,274,021 shares